Correspondence 0001185185-25-000555 from CLS Holdings USA, Inc. (CLSH) (CIK 0001522222)
CLS Holdings USA, Inc. (CLSH) (CIK 0001522222)
Date: May 28, 2025 · CIK: 0001522222 · Accession: 0001185185-25-000555
AI Filing Summary & Sentiment
File numbers found in text: 000-55546
Referenced dates: May 20, 2025
Show Raw Text
CORRESP
1
filename1.htm
Shelley
Detwiller DiGiacomo
(602) 222-4991
sdd@eblawyers.com
May
28, 2025
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
David Plattner
Re:
CLS Holdings USA, Inc. (the “Company”)
Schedule 13E-3/A filed May 20, 2025
File No. 005-89292
Preliminary Proxy Statement filed May 20, 2025
File No. 000-55546
Dear
Mr. Plattner:
The
following is in response to the comments set forth in your letter dated May 20, 2025. For ease of reference, each comment is repeated
verbatim, with our response immediately following.
Schedule
13E-3/A filed May 20, 2025; PRER14A filed May 20, 2025
General
1. We
note your response to prior comment 12. Please provide disclosure regarding the terms of
the loans that is fully responsive to the requirements set out in Item 1007(a)-(d) of Regulation
M-A, and please file as exhibits to the Schedule 13E-3 any documentation that is required
to be provided under Item 1016(b).
Response
We
have added disclosure describing the expected terms of the loans to the Preliminary Proxy Statement under “SPECIAL FACTORS—Purpose
and Reasons for the Reverse Stock Split” and added a copy of the form of secured promissory note as Exhibit 99.2 to the Schedule
13E-3.
2800 NORTH CENTRAL AVE. |
STE 1200 | PHOENIX, AZ 85004 | 602.271.9090 TEL | 602.222.4999 FAX | EBLAWYERS.COM
Engelman
Berger, P.C.
Attorneys
At Law
May
28, 2025
Page
2
2. Please
furnish a reasonably itemized statement of all expenses incurred or estimated to be incurred
in connection with the transaction. See Item 1007(c) of Regulation M-A.
Response
We
have added a table and narrative disclosure detailing the fees and expenses associated with the transaction in the Preliminary Proxy
Statement under “SPECIAL FACTORS—Purpose and Reasons for the Reverse Stock Split.”
3. We
note your response to prior comment 15. It is our impression that the Independent Committee
had access to the Houlihan presentation. Please therefore file such presentation as an exhibit
to the Schedule 13E-3.
Response
We
have added additional details from the Houlihan presentation to the Preliminary Proxy Statement under “DELIBERATIONS OF THE INDEPENDENT
COMMITTEE.” We have also added a copy of the Houlihan presentation to the Independent Committee as Exhibit 99.4.
4. We
note your response to prior comment 19. However, given the level of Mr. Koretsky’s
share ownership, and our understanding of his role as a lender to the Company both historically
and with respect to the current transaction, we believe that he should be considered an affiliate
engaged in the Rule 13e-3 transaction. Therefore, please add him as a filing person to the
Schedule 13E-3, and provide required disclosure accordingly, or, alternatively, provide a
detailed legal analysis as to why he should not in fact be considered an affiliate engaged
in the Rule 13e-3 transaction.
Response
We
have reconsidered our classification of Mr. Koretsky in light of your comments and have elected to consider him to be an affiliate. We
have added Mr. Koretsky as a filing person to the Schedule 13E-3. We have also revised our disclosure about Mr. Koretsky in the table
of 5% or greater stockholders in the Preliminary Proxy, provided information about Mr. Koretsky under “COMPANY INFORMATION—Information
about our Officers and Directors and Affiliated Shareholder” in the Preliminary Proxy, and made more specific disclosures about
his potential conflicts of interest under “POTENTIAL CONFLICTS OF INTEREST OF OFFICERS, DIRECTORS AND CERTAIN AFFILATED PERSONS”
in the Preliminary Proxy.
5. Please
see the previous comment. We note the disclosure on page 10 indicating that all shareholders
aside from the officers and directors are unaffiliated. In light of Mr. Koretsky’s apparent
status as an affiliate, please delete such statement, or advise.
Response
Please
see our response to Comment 4. We have revised to indicate that Mr. Koretsky is an affiliate and added additional disclosure.
Engelman
Berger, P.C.
Attorneys At Law
May 28, 2025
Page 3
6. We
note the following statement on page 10: “The majority of the unaffiliated security
holders present in person or by proxy at the Special Meeting will determine whether the reverse
stock split transaction is approved.” This statement appears to be inconsistent with
statements on pages 2 and 4 that indicate that Proposal 1 requires only the approval of votes
representing a majority of the shares entitled to vote and represented at the meeting in
person or by proxy. If true, please confirm that the latter disclosure is correct, and delete
the statement on page 10. Otherwise, please advise. In addition, and relatedly, please provide
a clear statement that is responsive to the disclosure requirement of Item 1014(c) of Regulation
M-A.
Response
We
have revised this disclosure to clarify that a majority of the security holders present in person or by proxy at the Special Meeting
will determine if the reverse stock split transaction is approved. We have added disclosure to indicate that the transaction has not
been structured to require the approval of the majority of unaffiliated security holders.
We
appreciate your assistance in our compliance with applicable disclosure requirements and in enhancing the overall disclosures in our
filings. Should you have any questions or comments regarding our responses, please feel free to contact me at 602-222-4991.
Sincerely,
Engelman Berger, P.C.
/s/ Shelley Detwiller DiGiacomo
Shelley Detwiller DiGiacomo